These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36498737)

  • 1. The Development of a Gleason Score-Related Gene Signature for Predicting the Prognosis of Prostate Cancer.
    Yimamu Y; Yang X; Chen J; Luo C; Xiao W; Guan H; Wang D
    J Clin Med; 2022 Dec; 11(23):. PubMed ID: 36498737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Set of Immune-associated Gene Signature predicts Biochemical Recurrence in Localized Prostate Cancer Patients after Radical Prostatectomy.
    Luan JC; Zhang QJ; Zhao K; Zhou X; Yao LY; Zhang TT; Zeng TY; Xia JD; Song NH
    J Cancer; 2021; 12(12):3715-3725. PubMed ID: 33995646
    [No Abstract]   [Full Text] [Related]  

  • 3. A Novel Four Mitochondrial Respiration-Related Signature for Predicting Biochemical Recurrence of Prostate Cancer.
    Xia Z; Liu H; Fan S; Tu H; Jiang Y; Wang H; Gu P; Liu X
    J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-gene signature associating with Gleason score serve as novel biomarkers for identifying early recurring events and contributing to early diagnosis for Prostate Adenocarcinoma.
    Zhang L; Li Y; Wang X; Ping Y; Wang D; Cao Y; Dai Y; Liu W; Tao Z
    J Cancer; 2021; 12(12):3626-3647. PubMed ID: 33995639
    [No Abstract]   [Full Text] [Related]  

  • 5. A new risk stratification system of prostate cancer to identify high-risk biochemical recurrence patients.
    Wu X; Lv D; Eftekhar M; Khan A; Cai C; Zhao Z; Gu D; Liu Y
    Transl Androl Urol; 2020 Dec; 9(6):2572-2586. PubMed ID: 33457230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Glycolysis-Related Five-Gene Signature Predicts Biochemical Recurrence-Free Survival in Patients With Prostate Adenocarcinoma.
    Xu Z; Xu L; Liu L; Li H; Jin J; Peng M; Huang Y; Xiao H; Li Y; Guan H
    Front Oncol; 2021; 11():625452. PubMed ID: 33954109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 10-gene signature as a predictor of biochemical recurrence after radical prostatectomy in patients with prostate cancer and a Gleason score ≥7.
    Wu X; Lv D; Lei M; Cai C; Zhao Z; Eftekhar M; Gu D; Liu Y
    Oncol Lett; 2020 Sep; 20(3):2906-2918. PubMed ID: 32782607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Basement membrane-related gene signature to predict biochemical recurrence in patients with prostate cancer after radical prostatectomy].
    Wang ZH; Liu Z; Zhao XD; Hu EY; Chen YH; Xu XF; Xia J; Liu YH; Dong J; Xu S; Cheng W
    Zhonghua Nan Ke Xue; 2022 Dec; 28(12):1071-1079. PubMed ID: 37846626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of a six immune-related gene signature for prediction of biochemical recurrence in localized prostate cancer following radical prostatectomy.
    Luan J; Zhang Q; Song L; Wang Y; Ji C; Cong R; Zheng Q; Xu Z; Xia J; Song N
    Transl Androl Urol; 2021 Mar; 10(3):1018-1029. PubMed ID: 33850736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Apoptosis-Related Gene Signature Predicts Biochemical Recurrence of Localized Prostate Cancer After Radical Prostatectomy.
    Zhang Q; Zhao K; Song L; Ji C; Cong R; Luan J; Zhou X; Xia J; Song N
    Front Genet; 2020; 11():586376. PubMed ID: 33329725
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification and Validation of a Prognostic 5-Protein Signature for Biochemical Recurrence Following Radical Prostatectomy for Prostate Cancer.
    Lv D; Cao Z; Li W; Zheng H; Wu X; Liu Y; Gu D; Zeng G
    Front Surg; 2021; 8():665115. PubMed ID: 34136527
    [No Abstract]   [Full Text] [Related]  

  • 12. Gene expression signature of Gleason score is associated with prostate cancer outcomes in a radical prostatectomy cohort.
    Jhun MA; Geybels MS; Wright JL; Kolb S; April C; Bibikova M; Ostrander EA; Fan JB; Feng Z; Stanford JL
    Oncotarget; 2017 Jun; 8(26):43035-43047. PubMed ID: 28496006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and validation of an E2F-related gene signature for predicting recurrence-free survival in human prostate cancer.
    Yang C; Chen L; Niu Q; Ge Q; Zhang J; Tao J; Zhou J; Liang C
    Cancer Cell Int; 2022 Dec; 22(1):382. PubMed ID: 36471446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting biochemical-recurrence-free survival using a three-metabolic-gene risk score model in prostate cancer patients.
    Zhao Y; Tao Z; Li L; Zheng J; Chen X
    BMC Cancer; 2022 Mar; 22(1):239. PubMed ID: 35246070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel defined risk signature based on pyroptosis-related genes can predict the prognosis of prostate cancer.
    Hu D; Cao Q; Tong M; Ji C; Li Z; Huang W; Jin Y; Tong G; Wang Y; Li P; Zhang H
    BMC Med Genomics; 2022 Feb; 15(1):24. PubMed ID: 35135561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel lysosome-related gene signature coupled with gleason score for prognosis prediction in prostate cancer.
    Huang Y; Yang F; Zhang W; Zhou Y; Duan D; Liu S; Li J; Zhao Y
    Front Genet; 2023; 14():1135365. PubMed ID: 37065491
    [No Abstract]   [Full Text] [Related]  

  • 17. Construction and validation of a fatty acid metabolism-related gene signature for predicting prognosis and therapeutic response in patients with prostate cancer.
    Zhao H; Wu T; Luo Z; Huang Q; Zhu S; Li C; Zhang Z; Zhang J; Zeng J; Zhang Y
    PeerJ; 2023; 11():e14854. PubMed ID: 36778142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical recurrence related metabolic novel signature associates with immunity and ADT treatment responses in prostate cancer.
    Wang X; Lv Z; Xia H; Guo X; Wang J; Wang J; Liu M
    Cancer Med; 2023 Jan; 12(1):862-878. PubMed ID: 35681277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a Ubiquitin Related Genes Signature for Predicting Prognosis of Prostate Cancer.
    Song G; Zhang Y; Li H; Liu Z; Song W; Li R; Wei C; Wang T; Liu J; Liu X
    Front Genet; 2021; 12():778503. PubMed ID: 35111198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.